5:1 Reverse Stock Split Decision, Capital Decrease of 1,000 Won
-
Reverse stock split ratio of 5:1 (par value from 500 KRW to 2,500 KRW), reducing total outstanding shares from 30,979,827 to 6,195,965
-
Capital decrease of 1,000 KRW due to fractional share handling (pre-split: 15,489,913,500 KRW, post-split: 15,489,912,500 KRW)
-
Purpose: stabilize stock price and enhance corporate value by maintaining an appropriate number of outstanding shares
-
Key schedule: General shareholders' meeting on 2026-07-06, effective date for new shares on 2026-08-07, listing date for new shares on 2026-08-27
-
Trading suspension period: from 2026-08-05 to 2026-08-26
KOSDAQ Filing Information
-
Filing: Stock Merger Decision
-
Company: ChoA Pharmaceutical (034940)
-
Submission: ChoA Pharmaceutical Co., LTD.
-
Receipt: 05-22-2026
-
Under KRX KOSDAQ Market Division